Education
About Us
Working with TipRanks
Follow Us
John A III Stalfort Insider Profile
11 Followers
John A III Stalfort, Director at Verrica Pharmaceuticals, holds 185.12K shares in Acumen Pharmaceuticals (Ticker: ABOS), holds 2.04M shares in Taysha Gene Therapies (Ticker: TSHA), holds 1.87M shares in Verrica Pharmaceuticals (Ticker: VRCA).
John A III Stalfort Verrica Pharmaceuticals (VRCA)Director
Verrica Pharmaceuticals (VRCA)
Director
Ranked #13,057 out of 103,225 Corporate Insiders
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+29.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John A III Stalfort holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 05, 2022 - Jul 05, 2023
Return:+136.80%
The most profitable trade made by John A III Stalfort
John A III Stalfort's Trading History
Verrica Pharmaceuticals
Nov 26, 2024
Director
Uninformative Buy
―
$10.61M
Dova Pharmaceuticals
Nov 12, 2019
―
Uninformative Sell
17.48M
$0.00
Acumen Pharmaceuticals
Jun 05, 2025
Director
Uninformative Buy
―
$257.32K
Taysha Gene Therapies
Jun 04, 2025
Director
Uninformative Buy
―
$6.06M
List of latest transactions for each holding click on a transaction to see John A III Stalfort's performance on stock
You May Also Like
John A III Stalfort insider profile FAQ
What is the percentage of profitable transactions made by John A III Stalfort?
The percentage of profitable transactions made by John A III Stalfort is 80%.
What is the average return per transaction made by John A III Stalfort?
The average return per transaction made by John A III Stalfort is 29.80%.
What stocks does John A III Stalfort hold?
John A III Stalfort holds: VRCA, DOVA, ABOS, TSHA stocks.
What was John A III Stalfort’s latest transaction?
John A III Stalfort latest transaction was an Uninformative Buy of ―.
What was John A III Stalfort's most profitable transaction?
John A III Stalfort’s most profitable transaction was an Informative Buy of VRCA stock on July 5, 2022. The return on the trade was 136.80%.
What is John A III Stalfort's role in Verrica Pharmaceuticals?
John A III Stalfort's role in Verrica Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.